Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Altria to revive vaping push with $2.8 billion NJOY bid after Juul fiasco

Published 03/06/2023, 07:10 AM
Updated 03/06/2023, 03:05 PM
© Reuters. FILE PHOTO: A woman poses with a cigarette in front of Altria logo in this illustration taken July 26, 2022. REUTERS/Dado Ruvic/Illustration

© Reuters. FILE PHOTO: A woman poses with a cigarette in front of Altria logo in this illustration taken July 26, 2022. REUTERS/Dado Ruvic/Illustration

By Deborah Mary Sophia

(Reuters) -Altria Group Inc said on Monday it would buy startup NJOY Holdings Inc for about $2.75 billion in cash, in a fresh bet by the Marlboro maker on the e-cigarette market after losing billions through its investment in Juul.

Big tobacco firms are investing heavily in traditional cigarette alternatives as smoking rates decline globally, but the e-cigarette category has faced tough regulatory scrutiny over under-age usage and health concerns.

Altria (NYSE:MO) is betting that NJOY will prove to be an easier way to tap the market since six of the company's products have received full approval from the U.S. Food and Drug Administration.

In comparison, Juul is still seeking approval of its products and is under the threat that the health regulator could pull its products off shelves nationwide as it briefly did last year.

"(NJOY) is an authorized product versus a pending product (from Juul). There are no litigation challenges. The youth usage is at minimum and so that brings a level of certainty," said Altria Chief Executive Officer Billy Gifford.

Still, NJOY's U.S. market share lags well behind that of Juul.

"If Altria wants to make NJOY successful enough so that its e-cig market share becomes somewhat respectable... we believe it will have to spend very aggressively," Barclays (LON:BARC) analysts said.

Altria on Friday exchanged its investment in Juul, last valued at $250 million, for some of the vaping company's heated tobacco intellectual property.

"We are no longer limited by the terms of those agreements to pursue other strategic opportunities and partnerships," Juul said.

Altria's stake in Juul, valued at $12.8 billion in 2018, had raised antitrust concerns and the Federal Trade Commission filed a complaint in April 2020. But an administrative law judge dismissed the complaint in February 2022.

© Reuters. FILE PHOTO: A woman poses with a cigarette in front of Altria logo in this illustration taken July 26, 2022. REUTERS/Dado Ruvic/Illustration

To help fund the deal, Altria said it would use cash from a $2.7 billion agreement it entered with Philip Morris International (NYSE:PM) last year for its IQOS heated tobacco products. 

The NJOY deal will include an additional $500 million in cash payments based on regulatory approvals of the company's other products.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.